These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24815838)

  • 1. Effect of dutasteride on microvessel density in benign prostatic hyperplasia.
    Sugie S; Mukai S; Tsukino H; Iwamoto H; Kobayashi T; Toda Y; Kamoto T
    In Vivo; 2014; 28(3):355-9. PubMed ID: 24815838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dutasteride for the treatment of benign prostatic hyperplasia.
    Wu C; Kapoor A
    Expert Opin Pharmacother; 2013 Jul; 14(10):1399-408. PubMed ID: 23750593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of the effects and mechanisms of preoperative 5α-reductase inhibitors on intraoperative haemorrhage during surgery for benign prostatic hyperplasia.
    Zong HT; Peng XX; Yang CC; Zhang Y
    Asian J Androl; 2011 Nov; 13(6):812-8. PubMed ID: 21892196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity.
    Busetto GM; Del Giudice F; Maggi M; Antonini G; D'Agostino D; Romagnoli D; Del Rosso A; Giampaoli M; Corsi P; Palmer K; Ferro M; Lucarelli G; Terracciano D; De Cobelli O; Sciarra A; De Berardinis E; Porreca A
    Aging (Albany NY); 2020 Mar; 12(5):4337-4347. PubMed ID: 32167484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.
    Page ST; Hirano L; Gilchriest J; Dighe M; Amory JK; Marck BT; Matsumoto AM
    J Urol; 2011 Jul; 186(1):191-7. PubMed ID: 21575967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of short-term dutasteride and Serenoa repens on perioperative bleeding and microvessel density in patients undergoing transurethral resection of the prostate.
    Tuncel A; Ener K; Han O; Nalcacioglu V; Aydin O; Seckin S; Atan A
    Scand J Urol Nephrol; 2009; 43(5):377-82. PubMed ID: 19921983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.
    Roehrborn CG; Nickel JC; Andriole GL; Gagnier RP; Black L; Wilson TH; Rittmaster RS
    Urology; 2011 Sep; 78(3):641-6. PubMed ID: 21764428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic evaluation of human benign prostatic hyperplasia treated by dutasteride: a study by xenograft model with improved severe combined immunodeficient mice.
    Tsujimura A; Fukuhara S; Soda T; Takezawa K; Kiuchi H; Takao T; Miyagawa Y; Nonomura N; Adachi S; Tokita Y; Nomura T
    Urology; 2015 Jan; 85(1):274.e1-8. PubMed ID: 25444635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of dutasteride on voiding and storage symptoms in men with benign prostatic hyperplasia].
    Tsukamoto T; Shirai T; Sakamoto S; Akiyama A; Takeuchi H; Yajima M; Terao T; Endo Y
    Hinyokika Kiyo; 2010 Dec; 56(12):677-82. PubMed ID: 21273805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transurethral Resection of Prostate and Bleeding: A Prospective, Randomized, Double-Blind Placebo-Controlled Trial to See the Efficacy of Short-Term Use of Finasteride and Dutasteride on Operative Blood Loss and Prostatic Microvessel Density.
    Bansal A; Arora A
    J Endourol; 2017 Sep; 31(9):910-917. PubMed ID: 28650680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of 5alpha-reductase inhibition with finasteride and dutasteride on bone mineral density in older men with benign prostatic hyperplasia.
    Mačukat IR; Spanjol J; Orlič ZC; Butorac MZ; Marinovič M; Ćupič DF
    Coll Antropol; 2014 Sep; 38(3):835-9. PubMed ID: 25420363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dutasteride in the treatment of benign prostatic hyperplasia: an update].
    Chen HJ; Chen YR
    Zhonghua Nan Ke Xue; 2011 Jan; 17(1):63-7. PubMed ID: 21351536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride.
    Kaplan SA; Chung DE; Lee RK; Scofield S; Te AE
    Int J Clin Pract; 2012 Nov; 66(11):1052-5. PubMed ID: 23067029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of dutasteride in Chinese adults with symptomatic benign prostatic hyperplasia: a randomized, double-blind, parallel-group, placebo-controlled study with an open-label extension.
    Na Y; Ye Z; Zhang S;
    Clin Drug Investig; 2012 Jan; 32(1):29-39. PubMed ID: 22017520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
    Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP
    BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS).
    Nickel JC; Gilling P; Tammela TL; Morrill B; Wilson TH; Rittmaster RS
    BJU Int; 2011 Aug; 108(3):388-94. PubMed ID: 21631695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effect of finasteride and dutasteride on chromogranin A levels.
    Sciarra A; Salciccia S; Nesi G; Cattarino S; Alfarone A; Gentilucci A; Gentile V
    Anticancer Res; 2010 Nov; 30(11):4737-42. PubMed ID: 21115933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Preoperative Dutasteride on Holmium Laser Enucleation of the Prostate.
    Shigemura K; Kitagawa K; Chen KC; Sung SY; Fujisawa M
    Urol Int; 2020; 104(5-6):356-360. PubMed ID: 31801152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.